A recent review examined sleep-related disorders linked to neurology and psychiatry, noting that the disorders degrade quality of life and functional ability, and recommended that when taking a patient history, specific questions are needed to probe the exact symptoms so as to enable strategic treatments.
After saying he would back a ban on flavored vapes, President Trump now says he wants to study the issue more; the FDA approved Novartis’ crizanlizumab (Adakveo) as both monotherapy and in combination for patients 16 years or older with sickle cell disease; the Federal Trade Commission will allow Bristol-Myers Squibb to purchase Celgene for $74 billion in cash and stocks.
Genetics plays a strong role in the the trajectory of the how psoriatic arthritis manifests in joint arthritis compared with skin disease.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An FDA committee unanimously agreed to expand the indication for Vascepa to include cardiovascular prevention; the number of enrollments through the HealthCare.gov marketplace has decreased 20% from last year; Dollar Tree has received a warning for selling medications imported from foreign manufacturers with safety violations.
In Australia, adults who are female, single, middle-aged, and have lower levels of education are more likely to experience less-than-optimal sleep, according to a recent study.
Financial assistance provided to patients in California who require dialysis is being threatened amid a new state law; WHO to certify insulins to curb rising prices; CDC warns of rising drug-resistant superbug threat.
Regulators and lawmakers have expressed concern over possible privacy breaches as Google and Ascension collect healthcare data; Amarin’s Vascepa goes before an FDA committee this week; CMS Administrator Seema Verma defends Medicaid work requirements.
EPA's new draft of their science transparency rule expands limitations on the use of science for agency rulemaking; cannabis-based medicine approved by National Health Service in England and Wales; medical care for mental health is expanding among adolescents.
Kaiser Permanente chairman and chief executive officer Bernard J. Tyson dies at 60; vitamin E acetate is linked as a potential cause of vaping-related lung injuries; Medicare’s outpatient premium cost is rising.
A recent study sought to identify an mRNA biomarker that predicts chemosensitivity across multiple solid tumor subtypes, given the significant heterogeneity in response among patients to chemotherapies.
HHS takes action against Gilead; a report on fears of seasonal workers in Montana; the latest CDC data on preventable deaths show differences between urban and rural areas.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
President Trump's conscience provision for medical providers was rejected by a New York federal Judge; a judge ordered the United States to administer mental healthcare to separated migrant families; a federal ban on flavored vaping products is near.
Medicaid work requirements were front and center in the outcomes of Kentucky governor's race as well as the statehouse in Virginia; the Trump administration called the drug plan from House Speaker Nancy Pelosi, D-California, "unworkable;" UnitedHealthcare is switching patients to biosimilar epoetin alfa in 2020;
Georgia Governor Brian Kemp released a Medicaid plan with a work requirement of 80 hours a month; a new Alzheimer drug derived from seaweed was given conditional approval in China; a study says California's vaccination law will have modest effect on childhood vaccination rates.
The Trump administration's requirement for immigrants to prove their ability to afford or obtain health insurance for visas has been blocked; 6 tips in choosing a health plan; FDA advises heartburn medication manufacturers to recall pills.
Two studies report that children who get measles are more susceptible to other illnesses later; Indiana decides not to pursuue Medicaid work requirements; a Trump administration rule taking effect mandating health insurance for new immigrants is causing confusion.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A lawsuit filed by a former executive of Juul claims they knowingly sold 1 million contaminated pods; Novartis trial for its Zolgensma gene therapy stopped amid safety concerns; charts show worsening air quality in Louisiana.
The number of uninsured children in the United States rose by more than 400,000 between 2016 and 2018 and now stands at over 4 million; mortality from heart failure rose 20.7% between 2011 and 2017 and is likely to keep climbing sharply; US District Judge Myron Thompson issued a preliminary injunction temporarily blocking Alabama from enforcing a near-total abortion ban.
The Committee for a Responsible Federal Budget released a detailed report on potential finance options for implementing "Medicare for All"; employers beginning to lessen dependence on high-deductible health plans; Juul to cut nearly 500 jobs by end of 2019.
States move to encourage work for Medicaid; the Trump administration imposes restrictions on immigrants using reciept of government benefits when applying for citizenship; FDA advises against cannabis use for pregnant women.
As HIV infection becomes a chronic illness, assessing psychosocial status regularly and implementing effective interventions aimed at related problems as they arise may be particularly important for people living with HIV to improve their health-related quality of life, a study suggests.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A CDC report said that, overall, fentanyl continues to drive drug overdose deaths, but in almost half of the country, methamphetamine is the leading killer; backers of Medicaid expansion in Oklahoma said they submitted more than enough signatures to get the measure on the ballot in 2020; the Federal Trade Commission is suing publishers of "The Doctor's Guide to Reversing Diabetes in 28 Days" on the grounds that they are falsely promising a cure without dietary changes or exercise and stating that those changes will make diabetes worse.
The FDA proposed new warnings on breast implants, requiring manufacturers to detail complications; Arizona suspends implementation of Medicaid work requirements; Amgen will lower the list price of evolocumab by 60%.
Republicans in the House of Representatives released their healthcare plan aimed at replacing the Affordable Care Act; Johnson & Johnson’s chief executive officer said in a deposition earlier this month that the company’s baby powder was free of asbestos 13 days before the FDA announced it had discovered the carcinogen in a container of the product; the House Ways and Means Committee will discuss a bill to to tax vape products at the same rate as cigarettes.
Student sick days are being expanded in some states to include mental health; vaped THC remains understudied due to its distinction as a controlled substance; drug company Biogen seeks approval for Alzheimer's treatment.
Two Ohio counties reached a $260 million settlement case with 4 opioid distributors; doctors stress the need for flu shots among pregnant women and those with chronic illnesses; a health system reports a data breach in its e-commerce website.
